BSE filing, BSE: 524548. Summary written from the filing by ALFA Finder's alert engine.
Sharma East India Hospitals & Medical Research Ltd: key numbers
- Share price
- ₹80.48
- Market cap
- ₹26.43 Cr
- Revenue (annual)
- ₹35.93 Cr
- Net profit (annual)
- ₹1.24 Cr
- P/E (TTM)
- 22.3×Sector 52.0×
- Promoter holding
- 53.63%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sharma East India Hospitals & Medical Research Ltd
All →Sharma East India Hospitals & Medical Research Other Announcement
Sharma East India Hospitals filed a Reg 74(5) SEBI (DP) dematerialization certificate for Q2 FY27. It is a routine RTA compliance confirmation with no new business content.
Sharma East India Hospitals & Medical Research Annual General Meeting
Sharma East India Hospitals & Medical Research Ltd. conducted its 37th Annual General Meeting on September 30, 2026, through video conferencing to transact ordinary business resolutions.
Sharma East India Hospitals & Medical Research Annual Report
Sharma East India Hospitals has filed its 37th Annual Report for FY 2025-2026. The report includes details concerning the upcoming Annual General Meeting.
Sharma East India Hospitals & Medical Research Annual General Meeting
The company approved its Annual Report and scheduled the 37th Annual General Meeting for September 30, 2026. Various AGM-related procedural dates were also finalized.
Sharma East India Hospitals & Medical Research Q1 FY27 Results: Net Profit ₹0.3 Cr, Up 0.0% YoY
Sharma East India Hospitals & Medical Research Ltd reported revenue from operations of ₹10.8 Cr (+13.7% YoY) and net profit of ₹0.3 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.3 Cr · +0.0% YoY
Sharma East India Hospitals & Medical Research Board Meeting Date
Sharma East India Hospitals will hold a board meeting on August 12, 2026, to approve the standalone un-audited financial results for the quarter ended June 30, 2026.
Other debt & borrowing announcements
All →Fusion Finance Debt & Borrowing: ₹1.35 Cr
Fusion Finance Limited paid Rs.1.35 Crore monthly interest on its non-convertible debentures on 28 October 2026. The payment was made on time, one day ahead of the stated due date of 29 October 2026.
- Value
- ₹1.35 Cr
Bajaj Finance Debt & Borrowing: ₹300 Cr
Bajaj Life Insurance purchased 30,000 NCDs of Bajaj Finance worth ₹300 Crore on NSE. The open-market debt buy signals promoter confidence in the company.
- Value
- ₹300.0 Cr
Fusion CX Debt & Borrowing: ₹21.85 Cr
Fusion CX lent up to Rs.21.85 Crore (USD 2.3 million) to wholly owned subsidiary Fusion BPO Services. Terms: 8.5% interest, three-year tenure, unsecured.
- Value
- ₹21.85 Cr
- Execution
- 3 years from the date of disbursal
Fusion CX Debt & Borrowing
Fusion CX Limited executed an unsecured inter-corporate term loan at 8.5% p.a. for three years with its wholly owned subsidiary Fusion BPO Services Ltd, a related party. Amount is not stated in the filing.
- Execution
- 3 years from the date of disbursal
Spandana Sphoorty Financial Debt & Borrowing: ₹0.49 Cr
Spandana paid ₹0.49 Crore of quarterly interest on its secured NCDs on 27 October 2026. The coupon rate is 10.75% on a ₹50 Crore issue.
- Value
- ₹0.49 Cr
Mangalam Worldwide Debt & Borrowing: ₹1.14 Cr
Mangalam Worldwide paid Rs. 1.14 Crore interest on its NCDs (ISIN INE0JYY07026) on 28 October 2026, net of TDS. The company confirmed timely payment under Regulation 57.
- Value
- ₹1.14 Cr